Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairs

Fig. 2

Construction of a risk assessment model and confirmation of the signature. (a, b) Results of the lasso regression. (c) The cutoff value of the one-year ROC curve was used to separate the patients. (d) Fourteen DEirlncRNA pairs were identified to construct the signature. (e) Distribution of lncRNA model risk scores. (f) Survival status of TC patients in the subgroups. (g) ROC analysis of the risk scores for overall prognosis prediction. The 3-(red), 5-(green), and 10-year (blue) ROC curves of the model suggested that all AUC values were over 0.95. (h) PCA plot of the lncRNA model. (i) Kaplan‒Meier curve presenting survival in the high-risk and low-risk sets

Back to article page